To determine the effectiveness and safety of a local application of inj Reptilase in comparison with Inj Ethamsylate in the management of patients with nasal bleeds, spontaneous, post-operative or post biopsy.
Phase 4
Completed
- Conditions
- Health Condition 1: null- Epistaxis, post-operative or post biopsy nasal bleeding.
- Registration Number
- CTRI/2008/091/000305
- Lead Sponsor
- Troikaa Pharmaceuticals Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Patients in the age group of 18 -60 years
Patients of both sexes
Patients presenting with epistaxis/ post-operative / post biopsy nasal bleeding.
Exclusion Criteria
Patients below 18 years and above 60 years of age
Patients with compromised vital organ function
Haemodynamically unstable patients.
Pregnant and lactating women.
Mentally retarded patients
Unwilling patients/ guardians
Patients with known hypersensitivity to any component of the formulation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method